|
STADA’s Stephan Eder sets Access, Manufacturing and Sustainability at heart of Medicines for Europe Presidency |
Medicines for Europe |
Mon, 01/13/2025 |
InfoSociety |
|
Maximising the impact of Biosimilar Medicines requires strategic action in Europe |
Medicines for Europe |
Thu, 12/05/2024 |
Health & Consumers |
|
Off-patent medicines industry marks 30 years of delivering public health impact |
Medicines for Europe |
Wed, 06/12/2024 |
Health & Consumers |
|
Reformed incentives system promises better patient access in Europe |
Medicines for Europe |
Tue, 06/11/2024 |
Health & Consumers |
|
Generic medicines: 70% of dispensed medicines and critical to healthcare |
Medicines for Europe |
Wed, 04/10/2024 |
Health & Consumers |
|
The future EU health agenda should bring EU solidarity to life |
Medicines for Europe |
Tue, 03/26/2024 |
Health & Consumers |
|
Vote to level up the European Health Union in upcoming elections |
Medicines for Europe |
Mon, 03/25/2024 |
Health & Consumers |
|
European Commission Biotech initiative must spearhead next wave of EU biosimilar advances for patients and stimulate manufacturing |
Medicines for Europe |
Thu, 03/21/2024 |
Health & Consumers |
|
Parliament compromise on pharmaceutical legislation accelerates much needed reform |
Medicines for Europe |
Tue, 03/19/2024 |
Health & Consumers |
|
Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays |
Medicines for Europe |
Wed, 02/28/2024 |
InfoSociety |
|
Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use |
Medicines for Europe |
Thu, 01/18/2024 |
InfoSociety |
|
Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines |
Medicines for Europe |
Tue, 11/07/2023 |
Health & Consumers |
|
A step forward for the secure supply of medicines and manufacturing and for public health |
Medicines for Europe |
Wed, 10/25/2023 |
Health & Consumers |
|
Time for the EU to take steps: a medicines security act is needed for health security |
Medicines for Europe |
Mon, 10/02/2023 |
Health & Consumers |
|
A streamlined, digital regulatory framework is the foundation for equitable access to medicines |
Medicines for Europe |
Wed, 09/27/2023 |
Health & Consumers |
|
European Parliament lends its support to a fair cost-based approach on EMA fees |
Medicines for Europe |
Fri, 06/30/2023 |
Health & Consumers |
|
Generic medicine pricing reforms needed in Slovakia to ensure supply for patients |
Medicines for Europe |
Fri, 06/23/2023 |
Health & Consumers |
|
EBA and Medicines for Europe signed a memorandum of agreement to accelerate Ukraine's integration into the EU pharmaceutical market |
Medicines for Europe |
Thu, 06/22/2023 |
Health & Consumers |
|
Off-patent medicines ready to drive pharma policy reform for equitable access, availability and security of medicines supply |
Medicines for Europe |
Thu, 06/15/2023 |
Health & Consumers |
|
Access to medicines and security of supply should be central to EU pharma and IP legislation reforms in Europe |
Medicines for Europe |
Tue, 06/13/2023 |
Health & Consumers |
|
EU must bolster biosimilar medicines policy to increase equity of access and bring much needed savings to healthcare budgets |
Medicines for Europe |
Thu, 05/25/2023 |
Health & Consumers |
|
Medicines for Europe joins the Antimicrobial (AMR) One Health Network |
Medicines for Europe |
Tue, 05/09/2023 |
Health & Consumers |
|
Future of pharmaceutical policy rests on secure supply of essential medicines |
Medicines for Europe |
Wed, 05/03/2023 |
Health & Consumers |
|
Patients should benefit from greater access under new patent package proposals |
Medicines for Europe |
Fri, 04/28/2023 |
Health & Consumers |
|
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform |
Medicines for Europe |
Thu, 04/27/2023 |
Health & Consumers |
|
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines |
Medicines for Europe |
Wed, 04/26/2023 |
Health & Consumers |
|
Market reforms needed to secure essential antibiotics against AMR, report says |
Medicines for Europe |
Thu, 02/16/2023 |
Health & Consumers |
|
EU can do more for equitable access to medicines |
Medicines for Europe |
Fri, 01/13/2023 |
Health & Consumers |
|
Billions more euros to re-invest in better healthcare thanks to biosimilar medicines |
Medicines for Europe |
Wed, 12/14/2022 |
Health & Consumers |
|
2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic |
Medicines for Europe |
Mon, 12/05/2022 |
Health & Consumers |
